Education
About Us
Working with TipRanks
Follow Us
Henrik Bergentoft Insider Profile
4 Followers
Henrik Bergentoft, Chief Financial Officer at Oncopeptides AB, holds 28.52K shares in Oncopeptides AB (Ticker: SE:ONCO). Most recently, Henrik Bergentoft Bought 5,184 shares of Oncopeptides AB on Sep 16, 2025 for an estimated value of kr16.59K.
Henrik Bergentoft Oncopeptides AB (ONCO)Chief Financial Officer
Oncopeptides AB (ONCO)
Chief Financial Officer
Ranked #85,927 out of 105,219 Corporate Insiders
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-33.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Henrik Bergentoft's holdings
Insider Roles
Chief Financial Officer
Roles that Henrik Bergentoft holds in companies
Most Profitable Insider Trade
The most profitable trade made by Henrik Bergentoft
Henrik Bergentoft's Trading History
List of latest transactions for each holding click on a transaction to see Henrik Bergentoft's performance on stock
You May Also Like
Henrik Bergentoft insider profile FAQ
What is the percentage of profitable transactions made by Henrik Bergentoft?
The percentage of profitable transactions made by Henrik Bergentoft is 33%.
What is the average return per transaction made by Henrik Bergentoft?
The average return per transaction made by Henrik Bergentoft is -33.90%.
What stocks does Henrik Bergentoft hold?
Henrik Bergentoft holds: SE:ONCO stocks.
What was Henrik Bergentoft’s latest transaction?
Henrik Bergentoft latest transaction was an Informative Buy of kr16.59K.
What was Henrik Bergentoft's most profitable transaction?
Henrik Bergentoft’s most profitable transaction was an Informative Buy of SE:ONCO stock on September 16, 2025. The return on the trade was 2.90%.
What is Henrik Bergentoft's role in Oncopeptides AB?
Henrik Bergentoft's role in Oncopeptides AB is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.